Log in to save to my catalogue

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb4008c8d293448e86fb08c2be9ef01a

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

About this item

Full title

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

Publisher

England: BioMed Central Ltd

Journal title

Journal of translational medicine, 2024-05, Vol.22 (1), p.516-516, Article 516

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Target cancer therapy has been developed for clinical cancer treatment based on the discovery of CRISPR (clustered regularly interspaced short palindromic repeat) -Cas system. This forefront and cutting-edge scientific technique improves the cancer research into molecular level and is currently widely utilized in genetic investigation and clinical...

Alternative Titles

Full title

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cb4008c8d293448e86fb08c2be9ef01a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb4008c8d293448e86fb08c2be9ef01a

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-024-05235-2

How to access this item